Salvi, Mario <br/><br/>
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  May 2009 
 - 360-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2008.12.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Cells, Cultured<br/>Female<br/>Graves Ophthalmopathy--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Immunologic Factors--pharmacology<br/>Lymphocytes--drug effects<br/>Male<br/>Middle Aged<br/>Orbit--drug effects<br/>Rituximab